Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A

International Journal of Pharmaceutics

Volumn 224, Issue 1-2, 2001, Pages 159-168

  De Campos, Angela M ^a   Sánchez, Alejandro ^a   Alonso, María J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Chitosan; Cyclosporin A; Drug delivery; Dry eye; Nanoparticles; Ocular; Topical

Indexed keywords

CHITOSAN; CYCLOSPORIN A; DRUG VEHICLE; ION; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TISSUE LEVEL; EYE DISEASE; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; TECHNIQUE; TIMED DRUG RELEASE; ZETA POTENTIAL;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIFUNGAL AGENTS; CHITIN; CHITOSAN; CONJUNCTIVA; CORNEA; CYCLOSPORINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EYE; MALE; MICROSCOPY, ELECTRON; MUCOUS MEMBRANE; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; RABBITS;

EID: 0035859983     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00760-8     Document Type: Article

References (31)

1. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs
2. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)
3. Immunophenotyping of human dendriform cells from the conjunctival epithelium
4. Corneal concentration and systemic absorption of cyclosporin-A following its topical application in the rabbit eye
5. Ocular penetration of cyclosporin A
6. Influence of topically applied cyclosporin A in olive oil on corneal epithelium permeability
7. Cyclosporin: Experience with therapeutic monitoring
8. Study of the mechanism of interaction of poly(e-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy
9. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A
10. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
11. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
12. Alteration of mucin in human conjunctival epithelia in dry eye
13. Chitosan nanoparticles as novel topical ocular drug delivery systems: Evaluation of the in vitro stability and the in vivo fate
14. The effect of topical cyclosporin on conjunctiva-associated lymphoid tissue (CALT)
15. Topical use of chitosan in ophthalmology: Tolerance assessment and evaluation of precorneal retention
16. Prolonged survival of allogenic corneal grafts in rabbits treated with topically applied cyclosporin A: Systemic absorption and local immunosuppressive effect
17. Nanospheres of cyclosporin A: Poor oral absorption in dogs
18. Bioadhesive microspheres for ophthalmic administration of acyclovir
19. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome
20. Chitosan: A biocompatible material for oral and intravenous administration
21. Intraocular penetration of topically applied cyclosporin
22. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: Treatment with cyclosporin eye drops
23. Characteristics of a canine model of keratoconjunctivitis sicca: Effective treatment of topical cyclosporin
24. Requirements of chitosan for pharmaceutical and biomedical applications
25. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
26. Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles
27. Design of new formulations for topical ocular administration: Polymeric nanocapsules containing metipranolol
28. The use of cyclosporine in ocular inflammatory disorders
29. Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjögren's syndrome
30. Idoxuridine-liposome therapy for herpes simplex keratitis
31. The pathology of dry eye: The interaction between the ocular surface and lacrimal glands